301065 Stock Overview
Engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Benli Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.05 |
| 52 Week High | CN¥25.26 |
| 52 Week Low | CN¥11.81 |
| Beta | 0.16 |
| 1 Month Change | -7.07% |
| 3 Month Change | 4.50% |
| 1 Year Change | -13.13% |
| 3 Year Change | -45.15% |
| 5 Year Change | n/a |
| Change since IPO | -63.54% |
Recent News & Updates
Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest
Nov 01
Recent updates
Zhejiang Benli Technology's (SZSE:301065) Performance Is Even Better Than Its Earnings Suggest
Nov 01What Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) 42% Share Price Gain Is Not Telling You
Aug 08Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year
Jun 19Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E
Jun 07We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings
May 02Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%
Mar 08Shareholder Returns
| 301065 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.8% | -1.7% | -1.0% |
| 1Y | -13.1% | -4.3% | 10.8% |
Return vs Industry: 301065 underperformed the CN Pharmaceuticals industry which returned -3% over the past year.
Return vs Market: 301065 underperformed the CN Market which returned 12.3% over the past year.
Price Volatility
| 301065 volatility | |
|---|---|
| 301065 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 301065 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301065's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 589 | Zhengjie Wu | www.benlitech.com |
Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. Its products include N,N-Dimethylamino ethyl acrylate; 2,4-Dichloro-5-fluorobenzoyl chloride; 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamino acrylate ethyl ester; 1-Ethyl-7-(1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; 2,4-Dichlorofluorobenzene; Methyl 3-Methoxyacrylate; Ethyl 3-ethoxyacrylate; 2,6-Dichlorofluorobenzene; 4-tert-Butylbenzoyl chloride; and 2, 4, 6-Trimethylbenzoyl chloride. The company was founded in 2011 and is based in Linhai, China.
Zhejiang Benli Technology Co., Ltd. Fundamentals Summary
| 301065 fundamental statistics | |
|---|---|
| Market cap | CN¥1.97b |
| Earnings (TTM) | CN¥62.17m |
| Revenue (TTM) | CN¥712.24m |
31.6x
P/E Ratio2.8x
P/S RatioIs 301065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301065 income statement (TTM) | |
|---|---|
| Revenue | CN¥712.24m |
| Cost of Revenue | CN¥590.85m |
| Gross Profit | CN¥121.38m |
| Other Expenses | CN¥59.21m |
| Earnings | CN¥62.17m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 17.04% |
| Net Profit Margin | 8.73% |
| Debt/Equity Ratio | 0.9% |
How did 301065 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield17%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 07:17 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Benli Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|